Vannucci Letizia, Brandi Maria Luisa
a Department of Surgery and Translational Medicine , University of Florence , Florence , Italy.
Expert Opin Pharmacother. 2016 Dec;17(17):2267-2272. doi: 10.1080/14656566.2016.1241765. Epub 2016 Oct 11.
Fracture healing is a complex physiological process. As impaired fracture healing is more frequent in osteoporotic subjects, anti-osteoporotic drugs could have some impact on this process. Areas covered: We reviewed the current literature to evaluate the effects of these drugs on fracture healing and their potential role in supporting this process, especially when impaired. A PubMed/Medline search was undertaken combining the terms 'fracture healing', 'anti-resorptive drugs', 'anabolic agents', 'anti-osteoporotic drugs'. Expert opinion: As clinical evidence on the role of anti-osteoporotic drugs in the process of fracture healing consists mainly of case reports or studies with a relatively small number of patients, large randomized clinical trials are needed in order to extend to the human setting the promising results on these agents as inductors or co-adjuvants of bone healing derived from animal studies.
骨折愈合是一个复杂的生理过程。由于骨质疏松患者骨折愈合受损更为常见,抗骨质疏松药物可能会对这一过程产生一定影响。涵盖领域:我们回顾了当前文献,以评估这些药物对骨折愈合的影响及其在支持这一过程中的潜在作用,尤其是在愈合受损时。通过结合“骨折愈合”“抗吸收药物”“促合成药物”“抗骨质疏松药物”等术语进行了PubMed/Medline检索。专家观点:由于关于抗骨质疏松药物在骨折愈合过程中作用的临床证据主要由病例报告或患者数量相对较少的研究组成,因此需要进行大型随机临床试验,以便将动物研究中这些药物作为骨愈合诱导剂或辅助剂所取得的有前景的结果推广至人体。